Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?—A multicenter EBMT-PDWP studyAndré Willasch, Adriana Balduzzi, Christina Peters et al.|Bone Marrow Transplantation|2020Cited by 61
Myeloablative Conditioning for First Allogeneic Hematopoietic Stem Cell Transplantation in Children with ALL: Total Body Irradiation or Chemotherapy? - a Multicenter EBMT-PDWP StudyAndré Willasch, Peter Bader, Christina Peters et al.|Blood|2017Cited by 2
Transplant Outcomes for Acute Myeloid Leukemia or Myelodysplastic Syndromes Secondary to Acquired Aplastic Anemia or Paroxysmal Nocturnal Hemoglobinuria: A Report from the EBMT Severe Aplastic Anemia Working PartyPedro Henrique Prata, Régis Peffault de Latour, Ain Kaare et al.|Blood|2023Cited by 2
Correction: Myeloablative conditioning for allo-HSCT in pediatric ALL: FTBI or chemotherapy?—A multicenter EBMT-PDWP studyAndré Willasch, Adriana Balduzzi, Christina Peters et al.|Bone Marrow Transplantation|2021Cited by 1
Hematopoietic stem cell transplantation is effective in achieving long-term survival for post-aplastic anemia myeloid neoplasms: the EBMT Severe Aplastic Anemia ReportPedro Henrique Prata, Régis Peffault de Latour, Dirk-Jan Eikema et al.|Haematologica|2025Cited by 0